Dr. Sandip Dey has been appointed as President – Institution Business at Entero Healthcare Solutions Ltd., strengthening the company’s senior leadership as it continues to scale its Hospitals & Institutions vertical across India. This appointment reflects Entero’s strategic intent to deepen its presence in the institutional healthcare segment and drive long-term, sustainable growth.
In his new role, Dr. Dey will be responsible for leading the strategic expansion and overall performance of the Hospitals & Institutions business nationwide. His mandate includes driving market penetration, improving profitability, and building enduring partnerships with hospitals, institutional buyers, and healthcare providers. He will report to Mr. Prabhat Agarwal, Managing Director & CEO, Entero Healthcare Solutions Ltd., and work closely with the leadership team to align institutional growth with the company’s broader business objectives.
Dr. Dey brings with him extensive leadership experience across the Indian pharmaceutical and healthcare ecosystem, having held senior roles at leading organisations such as Akumentis Healthcare, Nicholas Healthcare, Alkem Laboratories, Claris Lifesciences, Gland Pharma, Ipca Laboratories, Nicholas Piramal, and Dr. Reddy’s Laboratories. His career spans diverse therapeutic areas and business models, with a strong emphasis on institutional and hospital-led growth.
Over the years, he has built a strong reputation for scaling institution-focused businesses and critical care portfolios, often operating in roles that reported directly to Managing Directors and CEOs. His ability to combine strategic vision with execution discipline has enabled him to drive high-growth, high-impact healthcare businesses while navigating complex stakeholder environments within hospitals and large healthcare institutions.
With this appointment, Entero Healthcare Solutions further reinforces its commitment to leadership excellence and institutional market leadership. Dr. Dey’s deep domain knowledge, proven execution capabilities, and understanding of hospital and institutional dynamics are expected to play a pivotal role in strengthening Entero’s position as a trusted partner in India’s evolving healthcare landscape.